Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 20 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

14 recruiting

Enrollment Performance

Analytics

Early Phase 1
11(55.0%)
Phase 1
7(35.0%)
Phase 2
2(10.0%)
20Total
Early Phase 1(11)
Phase 1(7)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (20)

Showing 20 of 20 trials
NCT07560111Phase 2Not Yet Recruiting

A Phase II Study of GC101 in NSCLC

Role: lead

NCT07294872Phase 1Not Yet Recruiting

A Study of TIL in Advanced Solid Tumors (CZ)

Role: lead

NCT06120712Phase 1Completed

A Study of GC101 TIL in Advanced Melanoma (BZ)

Role: lead

NCT06828328Early Phase 1Recruiting

A Study of GC203 TIL in PDCA (RJ)

Role: lead

NCT07256756Phase 1Not Yet Recruiting

A Study of GC203 TIL in Advanced Solid Tumors (NF)

Role: lead

NCT04960072Early Phase 1Recruiting

A Study of GC101 TIL in r/r Gastrointestinal Tumors (10hospital)

Role: lead

NCT06703398Phase 2Recruiting

A Study of GC101 TIL in Advanced Melanoma

Role: lead

NCT06488950Early Phase 1Recruiting

A Study of TIL in Advanced Solid Tumors (DFGD)

Role: lead

NCT05142475Early Phase 1Recruiting

A Study of GC101 TIL in Advanced Breast Cancer (10hospital)

Role: lead

NCT05098197Early Phase 1Recruiting

A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)

Role: lead

NCT05098171Early Phase 1Recruiting

A Study of GC201 TIL in Advanced Gynecologic Tumors (10hospital)

Role: lead

NCT04967833Early Phase 1Recruiting

A Study of GC101 TIL in Advanced Solid Tumors (TR)

Role: lead

NCT06375187Phase 1Recruiting

A Study of GC203 TIL in Advanced Malignant Solid Tumors

Role: lead

NCT05468307Early Phase 1Completed

A Study of GC203 TIL in Advanced Gynecologic Tumors (10hospital)

Role: lead

NCT04943913Early Phase 1Recruiting

Study of GC101 TIL in Brain Glioma (Soochow2)

Role: lead

NCT06473961Phase 1Recruiting

A Phase Ib Study of GC101 in NSCLC

Role: lead

NCT05098184Early Phase 1Recruiting

A Study of GC101 TIL in Advanced Melanoma (10hospital)

Role: lead

NCT05417750Phase 1Completed

A Phase I Study of GC101 TIL in Advanced Solid Tumors

Role: lead

NCT05087745Early Phase 1Recruiting

A Clinical Study on TIL for the Treatment of Advanced Solid Tumors

Role: lead

NCT04766320Phase 1Recruiting

Study on TIL for the Treatment of r/r Gynecologic Tumors

Role: collaborator

All 20 trials loaded